Skip to Main Content

Author Details

Sahil Seth
The University of Texas MD Anderson Cancer Center
2014
36
26
PMIDPaper TitleJournal TitlePublished Year
37547448PTEN in triple-negative breast carcinoma: protein expression and genomic alteration in pretreatment and posttreatment specimens.Ther Adv Med Oncol2023
37547448PTEN in triple-negative breast carcinoma: protein expression and genomic alteration in pretreatment and posttreatment specimens.Ther Adv Med Oncol2023
35138907A functional genomic approach to actionable gene fusions for precision oncology.Sci Adv2022
35267631Prognostic Impact of High Baseline Stromal Tumor-Infiltrating Lymphocytes in the Absence of Pathologic Complete Response in Early-Stage Triple-Negative Breast Cancer.Cancers (Basel)2022
35138907A functional genomic approach to actionable gene fusions for precision oncology.Sci Adv2022
35267631Prognostic Impact of High Baseline Stromal Tumor-Infiltrating Lymphocytes in the Absence of Pathologic Complete Response in Early-Stage Triple-Negative Breast Cancer.Cancers (Basel)2022
34253579Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer.Clin Cancer Res2021
33745946Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal Cancer.Gastroenterology2021
33570852New Physicians, New Challenges: The Impact of Accelerated Graduation and Deployment Due to COVID-19.Acad Med2021
34039636Medium-Chain Acyl-CoA Dehydrogenase Protects Mitochondria from Lipid Peroxidation in Glioblastoma.Cancer Discov2021
34253579Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer.Clin Cancer Res2021
34857765The cytosolic iron-sulfur cluster assembly (CIA) pathway is required for replication stress tolerance of cancer cells to Chk1 and ATR inhibitors.NPJ Breast Cancer2021
34732714Inhibition of histone acetyltransferase function radiosensitizes CREBBP/EP300 mutants via repression of homologous recombination, potentially targeting a gain of function.Nat Commun2021
33570852New Physicians, New Challenges: The Impact of Accelerated Graduation and Deployment Due to COVID-19.Acad Med2021
33745946Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal Cancer.Gastroenterology2021
34857765The cytosolic iron-sulfur cluster assembly (CIA) pathway is required for replication stress tolerance of cancer cells to Chk1 and ATR inhibitors.NPJ Breast Cancer2021
34732714Inhibition of histone acetyltransferase function radiosensitizes CREBBP/EP300 mutants via repression of homologous recombination, potentially targeting a gain of function.Nat Commun2021
34039636Medium-Chain Acyl-CoA Dehydrogenase Protects Mitochondria from Lipid Peroxidation in Glioblastoma.Cancer Discov2021
32928921Allosteric SHP2 Inhibitor, IACS-13909, Overcomes EGFR-Dependent and EGFR-Independent Resistance Mechanisms toward Osimertinib.Cancer Res2020
32928921Allosteric SHP2 Inhibitor, IACS-13909, Overcomes EGFR-Dependent and EGFR-Independent Resistance Mechanisms toward Osimertinib.Cancer Res2020
30625329Functional Genomics Reveals Synthetic Lethality between Phosphogluconate Dehydrogenase and Oxidative Phosphorylation.Cell Rep2019
31610796Global impact of somatic structural variation on the DNA methylome of human cancers.Genome Biol2019
30625329Functional Genomics Reveals Synthetic Lethality between Phosphogluconate Dehydrogenase and Oxidative Phosphorylation.Cell Rep2019
30918400Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer.Nature2019
30726735Pre-existing Functional Heterogeneity of Tumorigenic Compartment as the Origin of Chemoresistance in Pancreatic Tumors.Cell Rep2019
30996079Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state.Sci Transl Med2019
31610796Global impact of somatic structural variation on the DNA methylome of human cancers.Genome Biol2019
30918400Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer.Nature2019
30726735Pre-existing Functional Heterogeneity of Tumorigenic Compartment as the Origin of Chemoresistance in Pancreatic Tumors.Cell Rep2019
30996079Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state.Sci Transl Med2019
29686388Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma.Nat Genet2018
30498242High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer.Nat Commun2018
29996110A Pan-Cancer Compendium of Genes Deregulated by Somatic Genomic Rearrangement across More Than 1,400 Cases.Cell Rep2018
29686388Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma.Nat Genet2018
29996110A Pan-Cancer Compendium of Genes Deregulated by Somatic Genomic Rearrangement across More Than 1,400 Cases.Cell Rep2018
30498242High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer.Nat Commun2018
28655737Evaluation and Design of Genome-Wide CRISPR/SpCas9 Knockout Screens.G3 (Bethesda)2017
28445736Systematic Epigenomic Analysis Reveals Chromatin States Associated with Melanoma Progression.Cell Rep2017
28528867A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations.Cancer Cell2017
28655737Evaluation and Design of Genome-Wide CRISPR/SpCas9 Knockout Screens.G3 (Bethesda)2017
28178232Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer.Nature2017
28135248Systematic analysis of telomere length and somatic alterations in 31 cancer types.Nat Genet2017
28135248Systematic analysis of telomere length and somatic alterations in 31 cancer types.Nat Genet2017
28445736Systematic Epigenomic Analysis Reveals Chromatin States Associated with Melanoma Progression.Cell Rep2017
28178232Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer.Nature2017
28528867A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations.Cancer Cell2017
27320920In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer.Cell Rep2016
27320920In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer.Cell Rep2016
27767028Genomic heterogeneity of multiple synchronous lung cancer.Nat Commun2016
27767028Genomic heterogeneity of multiple synchronous lung cancer.Nat Commun2016
  • 1 - 50 of 72

Recommended Authors

Case Western Reserve University
Career Start Year 2017
Number of shared co-authors 3
National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Career Start Year 2016
Number of shared co-authors 15
Washington University in St Louis
Career Start Year 2015
Number of shared co-authors 17
Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 5
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 2014
Number of shared co-authors 2
University Health Network
Career Start Year 2013
Number of shared co-authors 10
University of Colorado Denver | Anschutz Medical Campus
Career Start Year 2013
Number of shared co-authors 0
Princess Margaret Cancer Centre
Career Start Year 2012
Number of shared co-authors 14
Ontario Institute for Cancer Research
Career Start Year 2011
Number of shared co-authors 13
Memorial Sloan Kettering Cancer Center
Career Start Year 2011
Number of shared co-authors 5
College of Medicine, University of Saskatchewan
Career Start Year 2010
Number of shared co-authors 6
Universita del Piemonte Orientale
Career Start Year 2010
Number of shared co-authors 10
University of Bern
Career Start Year 2009
Number of shared co-authors 18
2Ontario Institute for Cancer Research
Career Start Year 2009
Number of shared co-authors 14
Dana-Farber Cancer Institute
Career Start Year 2009
Number of shared co-authors 46
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year 2008
Number of shared co-authors 15
University of Basel
Career Start Year 2008
Number of shared co-authors 8
The Netherlands Cancer Institute
Career Start Year 2008
Number of shared co-authors 3
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 13
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 19
Stanford University School of Medicine
Career Start Year 2004
Number of shared co-authors 11
Broad Institute of Harvard and MIT
Career Start Year 2004
Number of shared co-authors 24
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 61
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year 2003
Number of shared co-authors 14
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 45
Monash University
Career Start Year 2000
Number of shared co-authors 6
University of California san francisco
Career Start Year 1999
Number of shared co-authors 36
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 86
Francis Crick Institute
Career Start Year 1997
Number of shared co-authors 39
Broad Institute of Harvard and MIT
Career Start Year 1991
Number of shared co-authors 54

Collaborators

University of Texas MD Anderson Cancer Center
Co-authored papers 15
The University of Texas MD Anderson Cancer Center
Co-authored papers 13
The University of Texas MD Anderson Cancer Center
Co-authored papers 13
Co-authored papers 13
The University of MD Anderson Cancer Center
Co-authored papers 12
The University of MD Anderson Cancer Center
Co-authored papers 9
The University of MD Anderson Cancer Center
Co-authored papers 9
The University of Texas MD Anderson Cancer Center
Co-authored papers 8
Harvard Medical School
Co-authored papers 7
Co-authored papers 7
University of Chicago, USA University of Chicago Comprehensive Cancer Center
Co-authored papers 7
The University of Texas MD Anderson Cancer Center
Co-authored papers 7
Ulsan National Institute of Science and Technology (UNIST)
Co-authored papers 7
Harvard Medical School
Co-authored papers 6
Harvard Medical School, Brigham and Women's Hospital
Co-authored papers 6
University of Kentucky College of Medicine
Co-authored papers 6
Harvard Medical School
Co-authored papers 6
Harvard Medical School, Brigham and Women's Hospital
Co-authored papers 6
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 5
Co-authored papers 5
Istituto Europeo di Oncologia IRCCS
Co-authored papers 5
The University of MD Anderson Cancer Center
Co-authored papers 5
Co-authored papers 5
Co-authored papers 5
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Baylor College of Medicine
Co-authored papers 4
Cancer Research Center of Hawaii: University of Hawai'i Cancer Center.
Co-authored papers 3
Harvard Medical School, Brigham and Women's Hospital
Co-authored papers 3
Yale School of Medicine
Co-authored papers 3
Broad Institute
Co-authored papers 3